Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
11.72
+0.52 (4.64%)
At close: Sep 17, 2026, 4:00 PM EDT
11.76
+0.04 (0.34%)
After-hours: Sep 17, 2026, 4:39 PM EDT
Kura Oncology Market Cap
Kura Oncology has a market cap or net worth of $1.04 billion as of September 17, 2026. Its market cap has increased by 43.85% in one year.
Market Cap
1.04B
Enterprise Value
548.05M
1-Year Change
43.85%
Ranking
Category
Stock Price
$11.72
ChartMarket Cap Chart
Since November 5, 2015, Kura Oncology's market cap has increased from $113.70M to $1.04B, an increase of 816.99%. That is a compound annual growth rate of 22.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 1.04B | 15.32% |
| Dec 31, 2025 | 904.10M | 33.49% |
| Dec 31, 2024 | 677.30M | -36.58% |
| Dec 29, 2023 | 1.07B | 28.64% |
| Dec 30, 2022 | 830.20M | -10.90% |
| Dec 31, 2021 | 931.80M | -49.69% |
| Dec 31, 2020 | 1.85B | 197.24% |
| Dec 31, 2019 | 623.10M | 16.69% |
| Dec 31, 2018 | 534.00M | 15.51% |
| Dec 29, 2017 | 462.30M | 266.61% |
| Dec 30, 2016 | 126.10M | -29.75% |
| Dec 31, 2015 | 179.50M | 57.87% |
| Nov 5, 2015 | 113.70M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apnimed | 1.06B |
| Odyssey Therapeutics | 1.05B |
| Obsidian Therapeutics | 1.05B |
| MoonLake Immunotherapeutics | 1.04B |
| Janux Therapeutics | 1.01B |
| Arbutus Biopharma | 1.00B |
| SpyGlass Pharma | 968.65M |
| Adlai Nortye Group | 965.97M |